Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2005-1362PMID 16091477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.

  2005cited by this paper
• miR‐15a and miR‐16‐1 down‐regulation in pituitary adenomas

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.

  2005cited by this paper
• Impact of the Cyclooxygenase System on Doxorubicin-Induced Functional Multidrug Resistance 1 Overexpression and Doxorubicin Sensitivity in Acute Myeloid Leukemic HL-60 Cells

  2005cited by this paper
• Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase.

  2004cited by this paper
• Immunocytochemical characterization of two thyroid medullary carcinoma cell linesin vitro

  2004cited by this paper
• Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance

  2004cited by this paper
• Importance of P-glycoprotein at blood-tissue barriers.

  2004cited by this paper
• A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.

  2003cited by this paper
• Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.

  2003cited by this paper
• An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro.

  2003cited by this paper
• Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.

  2003cited by this paper
• Clinical review 158: Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer.

  2003cited by this paper
• Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma

  2002cited by this paper
• Regulation of MDR-1 (P-glycoprotein) by Cyclooxygenase-2*

  2002influential reference
• The role of COX-2 inhibitors in lung cancer.

  2002cited by this paper
• The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures

  2002cited by this paper
• Prostaglandin E2 Induces Hypoxia-inducible Factor-1α Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line*

  2002cited by this paper
• Cyclooxygenase-2 expression in thyroid nodules.

  2002cited by this paper
• Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line.

  2002cited by this paper
• Selective cyclooxygenase‐2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

  2002cited by this paper
• Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.

  2001cited by this paper
• Current approaches and perspectives in the therapy of medullary thyroid carcinoma

  2001cited by this paper
• Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.

  2001cited by this paper
• Treatment of medullary thyroid carcinoma: an update.

  2001cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society

  2000cited by this paper
• Androgen influences transforming growth factor-beta1 gene expression in human adrenocortical cells.

  2000cited by this paper
• The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

  2000cited by this paper
• Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research.

  2000cited by this paper
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  1998cited by this paper
• Molecular Targets in Oncology: Implications of the Multidrug Resistance Gene

  1993cited by this paper
• Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.

  1992cited by this paper
• Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.

  1991cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Androgen Influences Transforming Growth Factor-�1

  year unknowncited by this paper

• Organoids of patient-derived medullary thyroid carcinoma: the first milestone towards a new in vitro model in dogs.

  2022cites this paper
• Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.

  2019cites this paper
• The role of ABC transporters and inflammation in drug-resistant epilepsy

  2017influential citation
• Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.

  2017cites this paper
• Novel strategies to prevent the development of multidrug resistance (MDR) in cancer

  2017cites this paper
• Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1

  2016cites this paper
• Novel combination of Vincristine and COX-2 Inhibitor Nimesulide provides synergistic antiproliferative and pro-apoptotic effects in KOSC-2 oral squamous carcinoma cells

  2016cites this paper
• Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.

  2016cites this paper
• Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.

  2016cites this paper
• Utilizing the protein corona around silica nanoparticles for dual drug loading and release.

  2015cites this paper
• IGF-I Influences Everolimus Activity in Medullary Thyroid Carcinoma

  2015cites this paper
• Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice

  2014cites this paper
• Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines

  2014cites this paper
• N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis.

  2014cites this paper
• Immunohistochemical Expression of Potential Therapeutic Targets in Canine Thyroid Carcinoma

  2014influential citation
• Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression

  2014cites this paper
• Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells

  2014cites this paper
• Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.

  2013cites this paper
• Local bystander effect induces dormancy in human medullary thyroid carcinoma model in vivo.

  2013cites this paper
• New Diagnostic and Therapeutic Tools for Thyroid Cancer

  2013cites this paper
• Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma

  2013cites this paper
• Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.

  2013cites this paper
• The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.

  2012cites this paper
• Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.

  2012cites this paper
• Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4.

  2012cites this paper
• Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer.

  2012cites this paper
• Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro.

  2012cites this paper
• Modulation of apoptosis protein profiles--role of P-gp in HeLa cells exposed to doxorubicin.

  2012cites this paper
• New advances in the diagnosis, medical management and follow-up of medullary thyroid cancer

  2011cites this paper
• Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.

  2011cites this paper
• MCF-7 Breast Cancer Cell Line, a Model for the Study of the Association Between Inflammation and ABCG2-Mediated Multi Drug Resistance

  2011cites this paper
• Possible role of HSP60 in synergistic action of anthracyclines and sulindac in HeLa cells.

  2010cites this paper
• Rationale for the Use of Natural Anti-Inflammatory Agents in Cancer Chemotherapy

  2010cites this paper
• A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.

  2010cites this paper
• Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies

  2010cites this paper
• Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.

  2010cites this paper
• Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.

  2010cites this paper
• Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines

  2010cites this paper
• R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction.

  2010cites this paper
• Carcinogenesis and therapeutic strategies in thyroid cancer.

  2010cites this paper
• Sulindac Reverses Aberrant Expression and Localization of β-Catenin in Papillary Thyroid Cancer Cells with the BRAFV600E Mutation

  2010cites this paper
• Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-Glycoprotein/MDR1 in Caco-2 cells

  2009cites this paper
• Enhancement of Doxorubicin Cytotoxicity on Human Esophageal Squamous Cell Carcinoma Cells by Indomethacin and 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via Inhibiting P-Glycoprotein Activity

  2009influential citation
• Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies

  2009cites this paper
• Growth hormone excess promotes breast cancer chemoresistance.

  2009cites this paper
• Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB

  2009cites this paper
• Author's response to reviews Title: Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. Authors:

  2009influential citation
• Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study

  2009influential citation
• Novel treatment of medullary thyroid cancer

  2009cites this paper
• Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.

  2009cites this paper
• What is New on Thyroid Cancer Biomarkers

  2008cites this paper
• PHARMACOTHERAPY IN ADVANCED THYROID CANCER

  2008cites this paper
• Polymorphisms in Multidrug Resistance 1, Cyclooxygenase-2 and Breast Cancer Resistance Protein Genes and Risk of Colorectal Cancer, a prospective population based case control study. Running title: MDR1, COX-2, BCRP, NSAID, and Colorectal Cancer

  2008cites this paper
• The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells.

  2008cites this paper
• he adjuvant effects of Antrodia Camphorata extracts combined ith anti-tumor agents on multidrug resistant uman hepatoma cells

  2008cites this paper
• Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2.

  2008cites this paper
• Cyclooxygenase Inhibitors Down Regulate P-glycoprotein in Human Colorectal Caco-2 Cell Line

  2008cites this paper
• Eicosanoids and Resistance of Cancer Cells to Chemotherapeutic Agents

  2008cites this paper
• Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.

  2007cites this paper
• Reversal of doxorubicin resistance by adenovirus- mediated transfer of cyclooxygenase-2 antisense in multidrug-resistant MCF-7 cells

  2007cites this paper
• Recent advances in treatment of medullary thyroid carcinoma.

  2007cites this paper
• Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells.

  2007cites this paper
• Mise au point Recent advances in treatment of medullary thyroid carcinoma ☆

  2007cites this paper
• Le carcinome médullaire de la thyroïde : les nouvelles approches thérapeutiques

  2007cites this paper
• New molecular targeted therapies in thyroid cancer

  2006cites this paper
• Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.

  2006cites this paper
• Malignant Pheochromocytomas and Paragangliomas

  2006cites this paper